Category

• Pipeline2
• Products1

Organizations

• Bausch + Lomb61
• Eyes On Eyecare42
• Alcon, Inc.39
• American Optometric Association34
• Harrow26
• Glaukos25
• Aldeyra Therapeutics20
• Regeneron19
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• IOP3
• Glaucoma3
• Clinical Trials2
• Technology2
• FDA1
• Finance1

• Organizations: Myra Vision✕

Clear all

Pipeline

FDA green lights Myra Vision's IDE study for glaucoma

IDE approval enables company to initiate the open-label ADAPT study on its proprietary Calibreye TGT Surgical System.

Products

Myra Vision initiates FIH trial on Calibreye System for IOP reduction

Novel technology is being evaluated for use in open-angle glaucoma patients.

Pipeline

Myra Vision secures $25M for advancement of novel glaucoma treatment

The Shifamed portfolio company’s Calibreye System targets IOP reduction.